Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor

October 24, 2023 updated by: Duke University

A Randomized Comparison of Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor

The purpose of this research study is to compare induction of labor using a foley catheter bulb with a low dose of oxytocin versus a foley catheter bulb with an increasing dose of oxytocin. A foley catheter bulb with or without oxytocin is a common method of labor induction in patients whose cervix is not significantly dilated or thinned out (effaced). Oxytocin (pitocin) is a medicine used to increase the number and strength of the womb's contractions.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

121

Phase

  • Phase 4

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients with a singleton pregnancy
  2. Term pregnancy (> 37 weeks gestation)
  3. Age ≥ 18 years
  4. Bishop score < 5
  5. Contractions < 6/hr
  6. Reassuring fetal heart tracing

Exclusion Criteria:

  1. Rupture of membranes
  2. Antepartum bleeding
  3. Fetal death
  4. Placenta previa or low lying placenta
  5. Active genital herpes infection
  6. Previous use of an induction or preinduction agent during the current pregnancy
  7. EFW >4500 grams
  8. Non reassuring fetal testing
  9. Inability to pass foley through cervix
  10. Prior cesarean section

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: foley bulb induction with low dose pitocin
Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.
Other Names:
  • oxytocin
Active Comparator: foley bulb with standard incremental pitocin infusion protocol
Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.
Other Names:
  • oxytocin

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to the Second Stage of Labor
Time Frame: foley bulb placement until second stage of labor (during admission for delivery, up to approximately 4 days)
The second stage of labor was defined as the time from complete cervical dilation to delivery of the fetus.
foley bulb placement until second stage of labor (during admission for delivery, up to approximately 4 days)
Time to Delivery
Time Frame: foley bulb placement until delivery (during admission for delivery, up to approximately 4 days)
Time from foley balloon placement until neonate delivery
foley bulb placement until delivery (during admission for delivery, up to approximately 4 days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of Cesarean Delivery
Time Frame: during admission for delivery, up to approximately 4 days
Number of participants having a cesarean delivery
during admission for delivery, up to approximately 4 days
Time to Active Labor
Time Frame: during admission for delivery, up to approximately 4 days
Active labor was defined as the presence of regular, painful contractions and a minimum of 2 cm cervical dilation and complete effacement in nulliparous women or a minimum of 4 cm cervical dilation in multiparous women.
during admission for delivery, up to approximately 4 days
Time to Foley Expulsion or Removal
Time Frame: foley bulb placement until removal, up to 10 hours
Time from foley balloon placement until the expulsion or removal of the foley balloon.
foley bulb placement until removal, up to 10 hours
Incidence of Uterine Hyperstimulation
Time Frame: during admission for delivery, up to approximately 4 days
Uterine hyperstimulation (tachysystole) was defined as uterine contractions occurring greater than 12 in 20 minutes.
during admission for delivery, up to approximately 4 days
Neonatal Outcome: Birthweight
Time Frame: at time of birth (0 to 1 hour)
at time of birth (0 to 1 hour)
Neonatal Outcome: Placental Abruption
Time Frame: during admission for delivery, up to approximately 4 days
number of participants with placental abruption
during admission for delivery, up to approximately 4 days
Neonatal Outcome: Late Fetal Heart Rate Decelerations
Time Frame: during admission for delivery, up to approximately 4 days
Late fetal heart rate decelerations were defined as a gradual decrease in the fetal heart rate associated with uterine contraction with the nadir of the deceleration occurring after the peak of the contraction.
during admission for delivery, up to approximately 4 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Chad Grotegut, MD, Duke University
  • Principal Investigator: Brennan Fitzpatrick, MD, Duke University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2007

Primary Completion (Actual)

March 1, 2009

Study Completion (Actual)

March 1, 2009

Study Registration Dates

First Submitted

May 23, 2014

First Submitted That Met QC Criteria

May 27, 2014

First Posted (Estimated)

May 30, 2014

Study Record Updates

Last Update Posted (Actual)

October 26, 2023

Last Update Submitted That Met QC Criteria

October 24, 2023

Last Verified

June 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00001312

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Induction of Labor

Clinical Trials on pitocin

Subscribe